Abstract
The introduction of online adaptive magnetic resonance (MR)-guided radiation therapy (RT) has enabled safe treatment of pancreatic cancer with ablative doses. The aim of this review is to provide a comprehensive overview of the current literature on the use and clinical outcomes of MR-guided RT for treatment of pancreatic cancer. Relevant outcomes included toxicity, tumor response, survival and quality of life. The results of these studies support further investigation of the effectiveness of ablative MR-guided SBRT as a low-toxic, minimally-invasive therapy for localized pancreatic cancer in prospective clinical trials.
Original language | English |
---|---|
Pages (from-to) | 23-35 |
Number of pages | 13 |
Journal | Seminars in Radiation Oncology |
Volume | 34 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2024 |